Skip to main content
. Author manuscript; available in PMC: 2019 Apr 15.
Published in final edited form as: Immunopharmacol Immunotoxicol. 2014 Feb 5;36(2):182–186. doi: 10.3109/08923973.2013.864671

Figure 3:

Figure 3:

Flow Cytometry of Immune Cell Subsets Pretreatment and Week 7 on TLF. Core biopsies were obtained from patients 1001 and 1002 pre-treatment and week 7 on talactoferrin. The biopsy was taken either from a tumor-bearing site (1001-T and 1002-T) or a control biopsy was taken from an adjacent non-tumor containing site (1001-NT). Represented are percentages of different immune cell subsets detected by flow cytometry out of total immune cells or total T cells (for CD4+ and CD8+ T cell subsets). CD14 used as monocytes. CD56 and CD16 used for NK cells and CD56, CD16 and CD3 used for NK/T cells.